Open AccessThis article is
- freely available
ANRIL: Molecular Mechanisms and Implications in Human Health
Department of Geriatric Medicine and Nephrology, Osaka University Graduate School of Medicine, 2-2 B6, Yamadaoka, Suita, Osaka 565-0871, Japan
* Author to whom correspondence should be addressed.
Received: 6 November 2012; in revised form: 28 December 2012 / Accepted: 4 January 2013 / Published: 10 January 2013
Abstract: ANRIL is a recently discovered long non-coding RNA encoded in the chromosome 9p21 region. This locus is a hotspot for disease-associated polymorphisms, and it has been consistently associated with cardiovascular disease, and more recently with several cancers, diabetes, glaucoma, endometriosis among other conditions. ANRIL has been shown to regulate its neighbor tumor suppressors CDKN2A/B by epigenetic mechanisms and thereby regulate cell proliferation and senescence. However, the clear role of ANRIL in the pathogenesis of these conditions is yet to be understood. Here, we review the recent findings on ANRIL molecular characterization and function, with a particular focus on its implications in human disease.
Keywords: ANRIL; CDKN2BAS; polycomb proteins; 9p21
Citations to this Article
Cite This Article
MDPI and ACS Style
Congrains, A.; Kamide, K.; Ohishi, M.; Rakugi, H. ANRIL: Molecular Mechanisms and Implications in Human Health. Int. J. Mol. Sci. 2013, 14, 1278-1292.
Congrains A, Kamide K, Ohishi M, Rakugi H. ANRIL: Molecular Mechanisms and Implications in Human Health. International Journal of Molecular Sciences. 2013; 14(1):1278-1292.
Congrains, Ada; Kamide, Kei; Ohishi, Mitsuru; Rakugi, Hiromi. 2013. "ANRIL: Molecular Mechanisms and Implications in Human Health." Int. J. Mol. Sci. 14, no. 1: 1278-1292.